XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Research and development $ 2,148 $ 642
General and administrative 733 642
Selling and marketing expenses 70
Total operating expenses 2,951 1,284
Operating loss 2,951 1,284
Finance expenses (income), net (24) 2
Net Loss 2,927 1,286
Other comprehensive income:    
Foreign currency translation adjustment (6) (5)
Comprehensive loss for the period $ 2,921 $ 1,281
Basic net loss per common stock $ (0.12) $ (0.08)
Diluted net loss per common stock $ (0.12) $ (0.08)
Weighted average number of common stock outstanding used in computing basic net loss per share 24,959,768 15,503,632
Weighted average number of common stock outstanding used in computing diluted net loss per share 24,959,768 15,503,632